39

2

Logo

Corify Care SL

Company |

Primary tabs

About your organization

CORIFY Care SL (Corify) is a medical start-up focused on cardiac arrhythmias. We are developing a novel technology to improve the treatment of atrial fibrillation, which affects more than 30M patients worldwide. Corify vision is to become the world reference company in the prognosis and treatments of patients with cardiac arrhythmias.

Corify was founded by Andreu Climent and María Guillem, biomedical engineers, together with Felipe Atienza and Francisco Fernández-Avilés, world-renowned physiologists on cardiac arrhythmias. The technology originated at Hospital Universitario Gregorio Marañón (Madrid) and Universitat Politècnica de València.

The Strategic Research Agenda for cardiovascular disease (SRA-CVD) considers the improvement of the Atrial Fibrillation (AF) treatment a priority area. There are 10,7 million AF patients across Europe. By 2050, 2% of the population will be affected by AF. The effective treatment is ablation. However, more than 60% of persistent AF require several procedures, amounting to €13,5 billion in wasted healthcare costs.

Corify has developed ACORYS, a medical device, combining high-density electrodes, innovative image and biosignals processing technology and artificial intelligence. First, it helps with the diagnosis; Second, it guides surgeons during the ablation procedure.The advantage is double: a more precise diagnosis and more efficient surgery. ACORYS has been preliminarily validated with more than 150 patients in Spain and US.

News

Network (0)

There are no organizations in the network.

Recent activity

You are not connected

A certain number of contents are hidden from you and you do not benefit from the linking functionalities.

Log in or register to access to the entire contents and functionnalities. Subscription is quick and free.